1. Home
  2. RCKT vs LILA Comparison

RCKT vs LILA Comparison

Compare RCKT & LILA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • LILA
  • Stock Information
  • Founded
  • RCKT 1999
  • LILA 2017
  • Country
  • RCKT United States
  • LILA Bermuda
  • Employees
  • RCKT N/A
  • LILA N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • LILA Cable & Other Pay Television Services
  • Sector
  • RCKT Health Care
  • LILA Telecommunications
  • Exchange
  • RCKT Nasdaq
  • LILA Nasdaq
  • Market Cap
  • RCKT 264.0M
  • LILA 1.1B
  • IPO Year
  • RCKT N/A
  • LILA N/A
  • Fundamental
  • Price
  • RCKT $2.99
  • LILA $6.16
  • Analyst Decision
  • RCKT Buy
  • LILA Sell
  • Analyst Count
  • RCKT 13
  • LILA 1
  • Target Price
  • RCKT $18.50
  • LILA $6.50
  • AVG Volume (30 Days)
  • RCKT 3.8M
  • LILA 373.8K
  • Earning Date
  • RCKT 08-04-2025
  • LILA 08-05-2025
  • Dividend Yield
  • RCKT N/A
  • LILA N/A
  • EPS Growth
  • RCKT N/A
  • LILA N/A
  • EPS
  • RCKT N/A
  • LILA N/A
  • Revenue
  • RCKT N/A
  • LILA $4,441,000,000.00
  • Revenue This Year
  • RCKT N/A
  • LILA $2.45
  • Revenue Next Year
  • RCKT N/A
  • LILA $3.11
  • P/E Ratio
  • RCKT N/A
  • LILA N/A
  • Revenue Growth
  • RCKT N/A
  • LILA N/A
  • 52 Week Low
  • RCKT $2.19
  • LILA $4.26
  • 52 Week High
  • RCKT $26.98
  • LILA $10.82
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 45.55
  • LILA 59.44
  • Support Level
  • RCKT $2.76
  • LILA $6.00
  • Resistance Level
  • RCKT $3.24
  • LILA $6.53
  • Average True Range (ATR)
  • RCKT 0.19
  • LILA 0.23
  • MACD
  • RCKT 0.17
  • LILA 0.01
  • Stochastic Oscillator
  • RCKT 74.85
  • LILA 62.94

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About LILA Liberty Latin America Ltd.

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

Share on Social Networks: